0001415889-23-015860.txt : 20231205 0001415889-23-015860.hdr.sgml : 20231205 20231205163043 ACCESSION NUMBER: 0001415889-23-015860 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norkunas Matthew CENTRAL INDEX KEY: 0001816836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 231467060 MAIL ADDRESS: STREET 1: C/O GENERATION BIO CO. STREET 2: 301 BINNEY STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-12052023_041211.xml X0508 4 2023-12-01 0001733294 Generation Bio Co. GBIO 0001816836 Norkunas Matthew C/O GENERATION BIO CO., 301 BINNEY ST CAMBRIDGE MA 02142 false true false false CHIEF FINANCIAL OFFICER 0 Stock Option (right to buy) 1.39 2023-12-01 4 A 0 76310 0 A 2033-11-30 Common Stock 76310 76310 D The option to purchase 76,310 shares of common stock was granted on December 1, 2023. The shares underlying the option vest over two years, with 25% of the shares vesting on June 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Benjamin Waters, Attorney-in-Fact 2023-12-05